Payment overview · 2025
General Payments
$73.75
3 reported records · 3 companies
Healthcare provider profile · identity verified
David S Dunn, M.D.
Allopathic & Osteopathic Physicians|Internal Medicine · BEL AIR, MD · NPI 1700881315
Verified facts
What the public records show
CMS Open Payments records show David S Dunn, M.D. received $73.75 in general payments during 2025 across 3 reported records.
Novo Nordisk Inc accounted for 44.8% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 3 associated products.
Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Ozempic as an associated drug or biological on 261625 records involving 77793 distinct recipient NPIs. Public Medicare Part D data also shows 62 claims for Ozempic by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Novo Nordisk Inc | Unresolved — no canonical attribution shown | $33.02 | 44.8% | 1 | 2025 |
| Dynavax Technologies Corporation | Unresolved — no canonical attribution shown | $23.57 | 32.0% | 1 | 2025 |
| Medtronic, Inc. |
Medtronic, Inc. exact · evidence 2025-07-22 |
$17.16 | 23.3% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $73.75 | 3 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| Wegovy Normalized: wegovy |
Drug | Novo Nordisk Inc | $33.02 | 1 | 2025 |
Source payment records
|
|||||
| Heplisav-B Normalized: heplisav b |
Drug | Dynavax Technologies Corporation | $23.57 | 1 | 2025 |
Source payment records
|
|||||
| ABRE Normalized: abre |
Device | Medtronic, Inc. | $17.16 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| Novo Nordisk Inc Exact reporting entity; no affiliate inference |
2025 | Ozempic open payments reported associated product |
CMS Open Payments — General Payments 261625 supporting records · 77793 recipient NPIs · example record 1188130076 |
Ozempic · 2024 Exact normalized brand match · 1 Part D row |
62 | 12 |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 1130 | 278 |
| Levothyroxine Sodium | Levothyroxine Sodium | 867 | 161 |
| Amlodipine Besylate | Amlodipine Besylate | 800 | 163 |
| Furosemide | Furosemide | 676 | 155 |
| Lisinopril | Lisinopril | 667 | 179 |
| Metoprolol Succinate | Metoprolol Succinate | 616 | 139 |
| Escitalopram Oxalate | Escitalopram Oxalate | 611 | 122 |
| Potassium Chloride | Potassium Chloride | 593 | 99 |
| Pantoprazole Sodium | Pantoprazole Sodium | 546 | 107 |
| Quetiapine Fumarate | Quetiapine Fumarate | 514 | 82 |
| Eliquis | Apixaban | 508 | 93 |
| Trazodone Hcl | Trazodone Hcl | 493 | 94 |
| Metoprolol Tartrate | Metoprolol Tartrate | 485 | 75 |
| Gabapentin | Gabapentin | 481 | 110 |
| Sertraline Hcl | Sertraline Hcl | 481 | 78 |
| Mirtazapine | Mirtazapine | 472 | 101 |
| Omeprazole | Omeprazole | 464 | 104 |
| Losartan Potassium | Losartan Potassium | 459 | 99 |
| Donepezil Hcl | Donepezil Hcl | 315 | 48 |
| Tamsulosin Hcl | Tamsulosin Hcl | 299 | 68 |
| Clopidogrel | Clopidogrel Bisulfate | 274 | 63 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 270 | 67 |
| Simvastatin | Simvastatin | 250 | 59 |
| Memantine Hcl | Memantine Hcl | 249 | 37 |
| Meloxicam | Meloxicam | 247 | 61 |
| Alprazolam | Alprazolam | 237 | 52 |
| Tramadol Hcl | Tramadol Hcl | 234 | 57 |
| Carvedilol | Carvedilol | 227 | 48 |
| Buspirone Hcl | Buspirone Hcl | 216 | 37 |
| Pravastatin Sodium | Pravastatin Sodium | 207 | 36 |
| Hydrochlorothiazide | Hydrochlorothiazide | 205 | 54 |
| Montelukast Sodium | Montelukast Sodium | 205 | 47 |
| Xarelto | Rivaroxaban | 188 | 35 |
| Duloxetine Hcl | Duloxetine Hcl | 184 | 40 |
| Metformin Hcl | Metformin Hcl | 182 | 51 |
| Hydralazine Hcl | Hydralazine Hcl | 156 | 34 |
| Lorazepam | Lorazepam | 153 | 54 |
| Myrbetriq | Mirabegron | 153 | 19 |
| Allopurinol | Allopurinol | 152 | 43 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 149 | 21 |
| Levetiracetam | Levetiracetam | 149 | 28 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 144 | 29 |
| Fluticasone Propionate | Fluticasone Propionate | 137 | 50 |
| Famotidine | Famotidine | 121 | 38 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 121 | 75 |
| Divalproex Sodium | Divalproex Sodium | 118 | 21 |
| Jardiance | Empagliflozin | 115 | 31 |
| Nifedipine Er | Nifedipine | 114 | 16 |
| Oxycodone Hcl | Oxycodone Hcl | 114 | 24 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 112 | 23 |
| Prednisone | Prednisone | 108 | 40 |
| Januvia | Sitagliptin Phosphate | 106 | 20 |
| Clonazepam | Clonazepam | 104 | 20 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 101 | 12 |
| Bupropion Xl | Bupropion Hcl | 101 | 20 |
| Atenolol | Atenolol | 98 | 24 |
| Doxazosin Mesylate | Doxazosin Mesylate | 98 | 25 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 98 | 33 |
| Ondansetron Hcl | Ondansetron Hcl | 96 | 56 |
| Nystatin | Nystatin | 92 | 51 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 91 | 25 |
| Finasteride | Finasteride | 89 | 18 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 84 | 43 |
| Loperamide | Loperamide Hcl | 83 | 53 |
| Tizanidine Hcl | Tizanidine Hcl | 81 | 33 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 80 | 24 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 79 | 22 |
| Pregabalin | Pregabalin | 77 | 16 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 77 | 41 |
| Spironolactone | Spironolactone | 76 | 16 |
| Ropinirole Hcl | Ropinirole Hcl | 73 | 12 |
| Farxiga | Dapagliflozin Propanediol | 72 | 18 |
| Warfarin Sodium | Warfarin Sodium | 72 | 14 |
| Amiodarone Hcl | Amiodarone Hcl | 71 | 18 |
| Digoxin | Digoxin | 66 | 19 |
| Alendronate Sodium | Alendronate Sodium | 65 | 11 |
| Synthroid | Levothyroxine Sodium | 64 | 14 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 63 | 23 |
| Lansoprazole | Lansoprazole | 63 | 12 |
| Trulicity | Dulaglutide | 63 | 15 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 62 | 28 |
| Ozempic | Semaglutide | 62 | 12 |
| Cholestyramine | Cholestyramine (With Sugar) | 61 | 14 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 61 | 15 |
| Ibuprofen | Ibuprofen | 60 | 34 |
| Fluoxetine Hcl | Fluoxetine Hcl | 59 | 19 |
| Fenofibrate | Fenofibrate Nanocrystallized | 58 | 19 |
| Midodrine Hcl | Midodrine Hcl | 58 | 14 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 57 | 12 |
| Klayesta | Nystatin | 56 | 23 |
| Metoclopramide Hcl | Metoclopramide Hcl | 55 | 12 |
| Azithromycin | Azithromycin | 54 | 35 |
| Ezetimibe | Ezetimibe | 54 | 19 |
| Zolpidem Tartrate | Zolpidem Tartrate | 54 | 16 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 53 | 36 |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 52 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 51 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 51 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 50 | suppressed |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 50 | suppressed |
| Risperidone | Risperidone | 50 | suppressed |
| Torsemide | Torsemide | 50 | suppressed |
| Calcium Acetate | Calcium Acetate | 48 | suppressed |
| Cephalexin | Cephalexin | 48 | 35 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 48 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 47 | 12 |
| Gemtesa | Vibegron | 46 | 11 |
| Doxycycline Hyclate | Doxycycline Hyclate | 45 | 22 |
| Sucralfate | Sucralfate | 45 | suppressed |
| Aripiprazole | Aripiprazole | 44 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 43 | suppressed |
| Latanoprost | Latanoprost | 43 | 12 |
| Carbidopa-Levodopa Er | Carbidopa/Levodopa | 42 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 42 | 15 |
| Linzess | Linaclotide | 42 | suppressed |
| Novolog Flexpen | Insulin Aspart | 42 | suppressed |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 41 | 15 |
| Calcitriol | Calcitriol | 39 | suppressed |
| Celecoxib | Celecoxib | 39 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 39 | 32 |
| Nebivolol Hcl | Nebivolol Hcl | 39 | suppressed |
| Scopolamine | Scopolamine | 39 | suppressed |
| Temazepam | Temazepam | 39 | suppressed |
| Cefdinir | Cefdinir | 38 | 33 |
| Levofloxacin | Levofloxacin | 38 | 23 |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 38 | suppressed |
| Tradjenta | Linagliptin | 38 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 37 | 11 |
| Estradiol | Estradiol | 36 | suppressed |
| Fenofibrate | Fenofibrate | 35 | suppressed |
| Fluconazole | Fluconazole | 35 | 21 |
| Lovastatin | Lovastatin | 35 | suppressed |
| Fenofibrate | Fenofibrate,micronized | 34 | suppressed |
| Anastrozole | Anastrozole | 33 | suppressed |
| Baclofen | Baclofen | 33 | 11 |
| Metformin Hcl Er | Metformin Hcl | 33 | 13 |
| Methenamine Hippurate | Methenamine Hippurate | 33 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 33 | 11 |
| Azelastine Hcl | Azelastine Hcl | 32 | 13 |
| Irbesartan | Irbesartan | 32 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 32 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 31 | 12 |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 31 | 23 |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 30 | 11 |
| Diazepam | Diazepam | 30 | suppressed |
| Dropsafe Pen Needle | Pen Needle, Diabetic, Safety | 30 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 30 | 11 |
| Hydrocortisone | Hydrocortisone | 30 | suppressed |
| Irbesartan-Hydrochlorothiazide | Irbesartan/Hydrochlorothiazide | 30 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 30 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 30 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 29 | 11 |
| Bupropion Hcl | Bupropion Hcl | 29 | suppressed |
| Ondansetron Odt | Ondansetron | 29 | 28 |
| Glipizide Er | Glipizide | 28 | suppressed |
| Kapspargo Sprinkle | Metoprolol Succinate | 28 | suppressed |
| Nyamyc | Nystatin | 28 | 21 |
| Raloxifene Hcl | Raloxifene Hcl | 28 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 27 | suppressed |
| Naproxen | Naproxen | 27 | suppressed |
| Primidone | Primidone | 27 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 26 | suppressed |
| Entresto | Sacubitril/Valsartan | 26 | suppressed |
| Lidocaine | Lidocaine | 26 | suppressed |
| Abrysvo | Rsv Vacc, Pref A And Pref B/Pf | 25 | 25 |
| Amlodipine-Olmesartan | Amlodipine Bes/Olmesartan Med | 25 | suppressed |
| Metolazone | Metolazone | 25 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 25 | 14 |
| Ventolin Hfa | Albuterol Sulfate | 25 | 11 |
| Clindamycin Hcl | Clindamycin Hcl | 24 | 18 |
| Colchicine | Colchicine | 24 | 12 |
| Diltiazem 24hr Er | Diltiazem Hcl | 24 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 24 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 24 | suppressed |
| Carisoprodol | Carisoprodol | 23 | suppressed |
| Cilostazol | Cilostazol | 23 | suppressed |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 23 | 19 |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 23 | suppressed |
| Topiramate | Topiramate | 23 | suppressed |
| Valsartan | Valsartan | 23 | 11 |
| Cyclosporine | Cyclosporine | 22 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 22 | suppressed |
| Glimepiride | Glimepiride | 22 | suppressed |
| Methylprednisolone | Methylprednisolone | 22 | 21 |
| Verapamil Er | Verapamil Hcl | 22 | suppressed |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 21 | suppressed |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 21 | suppressed |
| Glipizide | Glipizide | 21 | suppressed |
| Lamotrigine | Lamotrigine | 21 | suppressed |
| Methocarbamol | Methocarbamol | 21 | suppressed |
| Morphine Sulfate | Morphine Sulfate | 21 | suppressed |
| Ramipril | Ramipril | 21 | suppressed |
| Hydromorphone Hcl | Hydromorphone Hcl | 20 | suppressed |
| Janumet | Sitagliptin Phos/Metformin Hcl | 20 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 20 | suppressed |
| Atenolol-Chlorthalidone | Atenolol/Chlorthalidone | 19 | suppressed |
| Gemfibrozil | Gemfibrozil | 19 | suppressed |
| Lyumjev Kwikpen U-100 | Insulin Lispro-Aabc | 19 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 18 | suppressed |
| Morphine Sulfate Er | Morphine Sulfate | 18 | suppressed |
| Santyl | Collagenase Clostridium Hist. | 18 | suppressed |
| Amoxicillin | Amoxicillin | 17 | 11 |
| Bupropion Hcl Sr | Bupropion Hcl | 17 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 17 | suppressed |
| Insulin Aspart Flexpen | Insulin Aspart | 17 | suppressed |
| Norethindron-Ethinyl Estradiol | Norethindrone Ac/Eth Estradiol | 17 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 16 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 16 | suppressed |
| Restasis | Cyclosporine | 16 | suppressed |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 16 | suppressed |
| Arnuity Ellipta | Fluticasone Furoate | 15 | suppressed |
| Dexamethasone | Dexamethasone | 15 | 14 |
| Oxycontin | Oxycodone Hcl | 15 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 14 | suppressed |
| Calcitonin-Salmon | Calcitonin,salmon,synthetic | 14 | suppressed |
| Diltiazem 24hr Er (La) | Diltiazem Hcl | 14 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 14 | suppressed |
| Ketorolac Tromethamine | Ketorolac Tromethamine | 14 | suppressed |
| Metronidazole | Metronidazole | 14 | 11 |
| Pilocarpine Hcl | Pilocarpine Hcl | 14 | suppressed |
| Rocklatan | Netarsudil Mesylat/Latanoprost | 14 | suppressed |
| Tadalafil | Tadalafil | 14 | suppressed |
| Vascepa | Icosapent Ethyl | 14 | suppressed |
| Bumetanide | Bumetanide | 13 | suppressed |
| Chlorthalidone | Chlorthalidone | 13 | suppressed |
| Desoximetasone | Desoximetasone | 13 | suppressed |
| Fiasp Flextouch | Insulin Aspart (Niacinamide) | 13 | suppressed |
| Hydroxyurea | Hydroxyurea | 13 | suppressed |
| Ibandronate Sodium | Ibandronate Sodium | 13 | suppressed |
| Lumigan | Bimatoprost | 13 | suppressed |
| Mesalamine Er | Mesalamine | 13 | suppressed |
| Nortriptyline Hcl | Nortriptyline Hcl | 13 | suppressed |
| Sulfasalazine | Sulfasalazine | 13 | suppressed |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 12 | suppressed |
| Combigan | Brimonidine Tartrate/Timolol | 12 | suppressed |
| Dorzolamide-Timolol | Dorzolamide Hcl/Timolol Maleat | 12 | suppressed |
| Folic Acid | Folic Acid | 12 | suppressed |
| Olanzapine | Olanzapine | 12 | suppressed |
| Valproic Acid | Valproic Acid (As Sodium Salt) | 12 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 12 | suppressed |
| Arexvy | Rsvpref3 Antigen/As01e/Pf | 11 | 11 |
| Butalb-Acetaminoph-Caff-Codein | Butalbit/Acetamin/Caff/Codeine | 11 | suppressed |
| Cefpodoxime Proxetil | Cefpodoxime Proxetil | 11 | suppressed |
| Desvenlafaxine Succinate Er | Desvenlafaxine Succinate | 11 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 11 | suppressed |
| Eszopiclone | Eszopiclone | 11 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 11 | suppressed |
| Metaxalone | Metaxalone | 11 | suppressed |
| Pertzye | Lipase/Protease/Amylase | 11 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 11 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 11 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $73.75 · 3 records | Novo Nordisk Inc | ABRE, Heplisav-B, Wegovy | 1 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- How do you evaluate evidence when you have a financial relationship with Novo Nordisk Inc?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error